SCHEMBL1508326

SCHEMBL1508326

O=C(O)CNC(=O)c1ccccc1S(=O)(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.54
CA1 P00915 5/20 0.47
CA2 P00918 5/20 0.47
CA9 Q16790 2/20 0.47
EGLN1 Q9GZT9 3/20 0.45
BCAT2 O15382 1/20 0.44
PTPRC P08575 2/20 0.43
CTSL P07711 1/20 0.43
PTPN13 Q12923 1/20 0.43
KDM4C Q9H3R0 1/20 0.42
DDX3X O00571 1/20 0.41
MMP1 P03956 2/20 0.41
MMP2 P08253 2/20 0.41
MMP9 P14780 2/20 0.41
MMP8 P22894 2/20 0.41
MMP13 P45452 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41
HIF1A Q16665 1/20 0.41
SLC22A6 Q4U2R8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14389506 0.83 KEAP1 (0.50) KEAP1CA1CA2CA9EGLN1
SCHEMBL31448014 0.82 KEAP1 (0.62) KEAP1EGLN1PTPRCCTSLPTPN13
SCHEMBL13972822 0.81 CA9 (0.49) CA1CA2CA9BCAT2DDX3X
SCHEMBL14088973 0.80 MAPK1 (0.56) HIF1A
SCHEMBL27489013 0.79 CA9 (0.73) CA1CA2CA9BCAT2DDX3X
SCHEMBL12923000 0.79 TSHR (0.56) CA1CA2CA9
SCHEMBL91950 0.78 KEAP1 (0.46) KEAP1CA1CA2CA9EGLN1
SCHEMBL30289977 0.77 KMT2A (0.65) KEAP1EGLN1KDM4CKDM4EMAPT
SCHEMBL27450922 0.77 KEAP1 (0.66) KEAP1EGLN1PTPRCCTSLPTPN13
SCHEMBL28410063 0.77 KEAP1 (0.50) KEAP1EGLN1KDM4CKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0514449-B1 NOVEL ANTI-TUMORAL AGENT DERIVED FROM DEXTRAN THERAPEUTIQUES SUBSTITUTIVES (FR) 1997-05-14 EP claimed
EP-0514449-A1 NOVEL ANTI-TUMORAL AGENT DERIVED FROM DEXTRAN. THERAPEUTIQUES SUBSTITUTIVES (FR) 1992-11-25 EP claimed
WO-1991012011-A1 NOVEL ANTI-TUMORAL AGENT DERIVED FROM DEXTRAN THERAPEUTIQUES SUBSTITUTIVES (FR) 1991-08-22 WO claimed
EP-0254616-A1 Process for obtaining novel protein fractions from growth factor preparations, the fractions, and their application as potentiating and stimulating agents, for growth factors CNRS, Centre National de la Recherche Scientifique (FR) 1988-01-27 EP claimed
WO-1988000207-A1 METHOD FOR OBTAINING NEW PROTEINIC FRACTIONS FROM GROWTH FACTOR ACTIVITIES, SAID FRACTIONS AND THEIR APPLICATION AS AGENTS FOR THE STIMULATION AND POTENTIALIZATION OF GROWTH FACTOR ACTIVITIES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS (FR) 1988-01-14 WO claimed
EP-3914225-A1 COSMETIC/DERMATOLOGICAL COMPOSITION Organes Tissus Régénération Réparation Remplacement (FR) 2021-12-01 EP disclosed
EP-3689327-A1 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PULMONARY LESIONS Organes Tissus Régénération Réparation Remplacement (FR) 2020-08-05 EP disclosed
WO-2020151900-A1 COSMETIC/DERMATOLOGICAL COMPOSITION ORGANES TISSUS REGENERATION REPARATION REMPLACEMENT (FR) 2020-07-30 WO disclosed
EP-3685822-A1 COSMETIC/DERMATOLOGICAL COMPOSITION Organes Tissus Régénération Réparation Remplacement (FR) 2020-07-29 EP disclosed
EP-2260853-B1 Biocompatible polymers for a medical composition ORGANES TISSUS RÉGÉNÉRATION RÉPARATION REMPLACEMENT (FR) 2015-10-21 EP disclosed
EP-2229947-B1 Biocompatible polymeres for a medicinal preparation ORGANES TISSUS RÉGÉNÉRATION RÉPARATION REMPLACEMENT (FR) 2015-07-01 EP disclosed
EP-1117695-B1 BIOCOMPATIBLE POLYMERS, COMPOSITIONS CONTAINING SAME AND THEIR USE FOR THE MANUFACTURE OF DRUGS BARRITAULT DENIS (FR) 2015-05-20 EP disclosed
EP-0514449-B1 NOVEL ANTI-TUMORAL AGENT DERIVED FROM DEXTRAN THERAPEUTIQUES SUBSTITUTIVES (FR) 1997-05-14 EP disclosed
EP-0514449-A1 NOVEL ANTI-TUMORAL AGENT DERIVED FROM DEXTRAN. THERAPEUTIQUES SUBSTITUTIVES (FR) 1992-11-25 EP disclosed
WO-1991012011-A1 NOVEL ANTI-TUMORAL AGENT DERIVED FROM DEXTRAN THERAPEUTIQUES SUBSTITUTIVES (FR) 1991-08-22 WO disclosed
WO-1991012011-A1 NOVEL ANTI-TUMORAL AGENT DERIVED FROM DEXTRAN THERAPEUTIQUES SUBSTITUTIVES (FR) 1991-08-22 WO disclosed
EP-0254616-A1 Process for obtaining novel protein fractions from growth factor preparations, the fractions, and their application as potentiating and stimulating agents, for growth factors CNRS, Centre National de la Recherche Scientifique (FR) 1988-01-27 EP disclosed
EP-0254616-A1 Process for obtaining novel protein fractions from growth factor preparations, the fractions, and their application as potentiating and stimulating agents, for growth factors CNRS, Centre National de la Recherche Scientifique (FR) 1988-01-27 EP disclosed
WO-1988000207-A1 METHOD FOR OBTAINING NEW PROTEINIC FRACTIONS FROM GROWTH FACTOR ACTIVITIES, SAID FRACTIONS AND THEIR APPLICATION AS AGENTS FOR THE STIMULATION AND POTENTIALIZATION OF GROWTH FACTOR ACTIVITIES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS (FR) 1988-01-14 WO disclosed
WO-1988000207-A1 METHOD FOR OBTAINING NEW PROTEINIC FRACTIONS FROM GROWTH FACTOR ACTIVITIES, SAID FRACTIONS AND THEIR APPLICATION AS AGENTS FOR THE STIMULATION AND POTENTIALIZATION OF GROWTH FACTOR ACTIVITIES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS (FR) 1988-01-14 WO disclosed